Status:
COMPLETED
ECoLoGiC Speech Therapy for Everyday Communication in Aphasia
Lead Sponsor:
University of Kansas Medical Center
Collaborating Sponsors:
National Center for Advancing Translational Sciences (NCATS)
Conditions:
Aphasia
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The primary goal of this clinical trial study is to evaluate the effect of a new therapy to improve talking in people with the language disability 'aphasia' after a stroke. The therapy is called: 'Exp...
Detailed Description
This study will be conducted with 7 people who have moderate to severe aphasia. Each person will receive ECoLoGiC Treatment. Since each person will receive the same therapy, they do not need to be ass...
Eligibility Criteria
Inclusion
- Inclusion Criteria for People with Aphasia:
- Age 18-85 years
- Self-reported adequate vision (aided), for testing procedures
- Pass a hearing screening (aided), in at least one ear at 40 decibels at 1000 Herz
- Monolingual speaker of English
- One or more left hemisphere stroke at least 6 months prior, leading to aphasia
- Right-handed prior to stroke
- Moderate to severe aphasia, as evaluated by the Western Aphasia Battery - Revised and clinical expertise
- Spoken language production of at least 2-3 word utterances (phrases or sentences), as evaluated by the Western Aphasia Battery - Revised and clinical expertise
- Reading comprehension of at least single words to short phrases, as evaluated by the Western Aphasia Battery - Revised and clinical expertise,
- Auditory comprehension for simple language, as evaluated by the Western Aphasia Battery - Revised and clinical expertise
- Exclusion Criteria for People with Aphasia:
- Younger than 18
- Older than 85
- Self-reported vision impairment preventing completion of testing (aided)
- Unable to pass hearing screening in at least one ear at 40 decibels at 1000 Herz (aided)
- Multilingual speaker (language proficiency of greater than 4 out of 7 on reading, writing, speaking, or listening in any language other than English; self-rating bilingualism scale)
- Minimal, mild, or profound aphasia as evaluated by the Western Aphasia Battery - Revised and clinical expertise
- Severe cognitive impairment as evaluated by the Cognitive Linguistic Quick Test - Plus and clinical expertise
- No greater than a score of 2.5 on the Apraxia of Speech Rating Scale
- No greater than 3.0 on the Dysarthria-in-Interaction Profile
- Use of an alternative augmentative communication device as primary means of communication
- Spoken language production consisting of single word or no verbal communication, as evaluated by the Western Aphasia Battery - Revised and clinical expertise
- Inability to comprehend simple language in conversation, as evaluated by the Western Aphasia Battery - Revised and clinical expertise
- Inability to read single words for comprehension, as evaluated by the Western Aphasia Battery - Revised and clinical expertise
- Neurological injury or condition other than left hemisphere stroke
- Left-handed before stroke
- Learning or language disability
- Uncontrolled mental health condition
- Inclusion Criteria for Family Members:
- Pass a hearing screening (aided), in at least one ear at 40 decibels at 1000 Herz
- Cognitive function within normal limits as evaluated by the Montreal Cognitive Assessment
- Must speak English
- Exclusion Criteria for Family Members:
- Unable to pass hearing screening in one ear at 40 decibels at 1000 Herz (aided)
- Cognitive status below within normal limits cut-off score as evaluated by the Montreal Cognitive Assessment
Exclusion
Key Trial Info
Start Date :
January 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06132464
Start Date
January 3 2024
End Date
June 30 2024
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kansas University Medical Center
Kansas City, Kansas, United States, 66160